PFA Pension Forsikringsaktieselskab purchased a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 268,123 shares of the company's stock, valued at approximately $55,558,000. PFA Pension Forsikringsaktieselskab owned about 0.11% of Cardinal Health as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Redhawk Wealth Advisors Inc. raised its stake in Cardinal Health by 0.5% in the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company's stock valued at $1,902,000 after buying an additional 48 shares during the last quarter. HF Advisory Group LLC raised its stake in Cardinal Health by 0.9% in the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company's stock valued at $1,074,000 after buying an additional 49 shares during the last quarter. Latitude Advisors LLC raised its stake in Cardinal Health by 2.1% in the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company's stock valued at $408,000 after buying an additional 53 shares during the last quarter. Barnes Dennig Private Wealth Management LLC raised its stake in Cardinal Health by 38.7% in the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company's stock valued at $39,000 after buying an additional 53 shares during the last quarter. Finally, MFA Wealth Services raised its stake in Cardinal Health by 2.3% in the third quarter. MFA Wealth Services now owns 2,491 shares of the company's stock valued at $391,000 after buying an additional 55 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several brokerages have recently issued reports on CAH. Wells Fargo & Company reduced their price objective on Cardinal Health from $256.00 to $245.00 and set an "overweight" rating for the company in a research note on Friday. Evercore dropped their target price on Cardinal Health from $260.00 to $240.00 and set an "outperform" rating on the stock in a report on Wednesday, April 8th. William Blair initiated coverage on Cardinal Health in a report on Tuesday. They set an "outperform" rating on the stock. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Cardinal Health in a report on Monday, April 20th. Finally, JPMorgan Chase & Co. raised their target price on Cardinal Health from $209.00 to $243.00 and gave the stock a "neutral" rating in a report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $243.67.
Check Out Our Latest Stock Report on Cardinal Health
Cardinal Health Stock Performance
Shares of Cardinal Health stock opened at $195.13 on Friday. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The company has a market cap of $45.92 billion, a price-to-earnings ratio of 29.84, a PEG ratio of 1.20 and a beta of 0.53. The business's 50 day moving average price is $213.73 and its 200 day moving average price is $205.82.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the previous year, the business earned $2.35 earnings per share. The company's revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Wednesday, April 1st. Cardinal Health's dividend payout ratio is currently 29.35%.
Key Headlines Impacting Cardinal Health
Here are the key news stories impacting Cardinal Health this week:
- Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
- Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
- Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
- Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
- Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
- Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
- Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage
About Cardinal Health
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Recommended Stories
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.